Truvestments Capital’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $59 | Hold |
50
| – | – | ﹤0.01% | 936 |
|
2025
Q1 | $62 | Hold |
50
| – | – | ﹤0.01% | 1007 |
|
2024
Q4 | $61 | Hold |
50
| – | – | ﹤0.01% | 996 |
|
2024
Q3 | $148 | Buy |
+50
| New | +$148 | ﹤0.01% | 906 |
|
2024
Q2 | – | Sell |
-50
| Closed | -$93 | – | 237 |
|
2024
Q1 | $93 | Hold |
50
| – | – | ﹤0.01% | 713 |
|
2023
Q4 | $156 | Hold |
50
| – | – | ﹤0.01% | 774 |
|
2023
Q3 | $198 | Hold |
50
| – | – | ﹤0.01% | 664 |
|
2023
Q2 | $171 | Hold |
50
| – | – | ﹤0.01% | 677 |
|
2023
Q1 | $183 | Hold |
50
| – | – | ﹤0.01% | 654 |
|
2022
Q4 | $472 | Sell |
50
-31
| -38% | -$293 | ﹤0.01% | 870 |
|
2022
Q3 | $1K | Hold |
81
| – | – | ﹤0.01% | 579 |
|
2022
Q2 | $2K | Buy |
+81
| New | +$2K | ﹤0.01% | 548 |
|
2022
Q1 | – | Sell |
-81
| Closed | -$2K | – | 193 |
|
2021
Q4 | $2K | Hold |
81
| – | – | ﹤0.01% | 543 |
|
2021
Q3 | $3K | Hold |
81
| – | – | ﹤0.01% | 497 |
|
2021
Q2 | $3K | Hold |
81
| – | – | ﹤0.01% | 503 |
|
2021
Q1 | $4K | Sell |
81
-26
| -24% | -$1.28K | ﹤0.01% | 533 |
|
2020
Q4 | $3K | Buy |
+107
| New | +$3K | ﹤0.01% | 521 |
|
2020
Q3 | – | Sell |
-107
| Closed | -$4K | – | 320 |
|
2020
Q2 | $4K | Buy |
+107
| New | +$4K | ﹤0.01% | 467 |
|
2019
Q4 | – | Sell |
-182
| Closed | -$6K | – | 153 |
|
2019
Q3 | $6K | Sell |
182
-16
| -8% | -$527 | ﹤0.01% | 546 |
|
2019
Q2 | $8K | Hold |
198
| – | – | 0.01% | 548 |
|
2019
Q1 | $14K | Buy |
+198
| New | +$14K | 0.01% | 458 |
|
2018
Q3 | $11K | Buy |
+206
| New | +$11K | 0.01% | 612 |
|